BioSpace News Archive

The presence of multiple players has fragmented the Latin America pharmaceutical products and CMO market.

The consequences of lifestyle diseases are aplenty. One condition like obesity, hypertension, or diabetes which are also result of stress, can be dangerous to the entire body.

Following further analysis and considerations, the Board has decided to withdraw the dividend proposal of SEK 1.60 per share and instead propose that no dividend be paid in connection with the annual general meeting.

Preserving biological samples against contamination, which can be caused merely via exposure to the environment, is paramount for those operating in the fields of pharmaceuticals, biopharmaceuticals, diagnostic and testing laboratories, and research academies.

Highlight Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces that it has changed its name from Bioncotech with immediate effect.

Todos Medical Ltd. (OTCQB: TOMDF), a commercial in vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders as well as point-of-care and lab-based tests for COVID-19, announces the appointment of Lauren Chung, Ph.D. to its Board of Directors.

Genetic Technologies Limited has developed a detailed implementation plan to enable a temporary transition of our genetic testing laboratory to a high-throughput COVID-19 testing laboratory, should it be required by Government agencies to assist with demand.

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC QB: IPATF) is pleased to provide an update on its research activities for the novel coronavirus (SARS-CoV-2) which outlines the Company’s workflows for their experimental vaccines and therapeutics for the research community.

Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has commenced Phase I clinical trial, a randomized, double-blinded, placebo controlled study, for its vaccine candidate against COVID-19. Enrollment of the first group of volunteers and the first dose of vaccination for these volunteers have been completed. This study i

New patient registry is also now available to all hospitals willing to capture meaningful data about their COVID-19 patients